Midkine in inflammation

80Citations
Citations of this article
65Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The 13kDa heparin-binding growth factor midkine (MK) was originally identified as a molecule involved in the orchestration of embryonic development. Recent studies provided evidence for a new role of MK in acute and chronic inflammatory processes. Accordingly, several inflammatory diseases including nephritis, arthritis, atherosclerosis, colitis, and autoimmune encephalitis have been shown to be alleviated in the absence of MK in animal models. Reduced leukocyte recruitment to the sites of inflammation was found to be one important mechanism attenuating chronic inflammation when MK was absent. Furthermore, MK was found to modulate expression of proinflammatory cytokines and the expansion of regulatory T-cells. Here, we review the current understanding of the role of MK in different inflammatory disorders and summarize the knowledge of MK biology. Copyright © 2011 Ludwig T. Weckbach et al.

Author supplied keywords

Cite

CITATION STYLE

APA

Weckbach, L. T., Muramatsu, T., & Walzog, B. (2011). Midkine in inflammation. TheScientificWorldJournal. https://doi.org/10.1100/2011/517152

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free